Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05083351 · ClinicalTrials.gov registry record · NA
Performance of Masimo MightySat Pulse Oximeter in Differing Levels of Skin Pigmentation
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT05083351 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 88 participants.
The verdict
NCT05083351, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
Evaluation of the noninvasive oxygen saturation (SpO2) performance of the noninvasive Masimo MightySat against reference arterial blood samples analyzed by a laboratory CO-oximeter reference instrument. The study will include different subgroups to assess the performance across different genders and skin pigmentation.
Interventions
- DEVICE MightySat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2021-10-13 |
| Est. Completion | 2021-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05083351
The ClinicalTrials.gov registry entry for NCT05083351 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MightySat is the first listed.
NCT05083351 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05083351 about?
NCT05083351 is a clinical study titled "Performance of Masimo MightySat Pulse Oximeter in Differing Levels of Skin Pigmentation". Evaluation of the noninvasive oxygen saturation (SpO2) performance of the noninvasive Masimo MightySat against reference arterial blood samples analyzed by a laboratory CO-oximeter reference instrument. The study will include different subgroups to assess the performance across different genders and...
What is the current status of trial NCT05083351?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2021-10-13. Estimated completion is 2021-12-17.
What interventions are being tested in trial NCT05083351?
The interventions under investigation include: MightySat (DEVICE).
Who is sponsoring clinical trial NCT05083351?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.